Whilst reduced-count MBL rarely progresses to CLL, large-count MBL progresses to CLL requiring therapy at a price of 1% to two% per annum. Significant-count MBL is distinguished from Rai 0 CLL determined by whether or not the B-mobile count is previously mentioned or underneath five × 109/L. Although folks with both equally superior-count MBL and